Skip to content

Mar 11 Trending Stocks and Price Prediction – Novo Nordisk, Crowdstrike, Taiwan Semiconductor

Taiwan Semiconductor Mfg. Co. Ltd. – Price Prediction

NYSE: TSM : $137.5

For Taiwan Semiconductor Mfg. Co. Ltd. (TSM), the stock price predictions heading into 2025 show a range of expectations among analysts. The 12-month price forecasts from various analysts have an average target of approximately $137.5, with a high estimate reaching up to $160 and a low estimate at $115​​. WallStreetZen also indicates an average forecast of $133.33 by 2025, with their predictions ranging from $115 to $160​​.

Considering the current market dynamics and the competitive landscape that includes major players like Intel and Samsung, TSMC is still expected to hold a strong position in the semiconductor industry. Despite challenges, the overall sentiment appears to be optimistic, with a consensus towards buying TSM stock​​.

Based on this information, my opinion is that TSMC’s stock price could potentially reach towards the higher end of these forecasts by 2025, especially considering the company’s robust position in the semiconductor industry and ongoing growth in demand for semiconductors. However, it’s important to stay aware of the competitive and geopolitical risks that could impact these predictions.

Novo Nordisk A/S – Price Prediction

NYSE: NVO : $152.12

The long-term forecasts for Novo Nordisk A/S (NVO) present a rather optimistic view towards 2025 and beyond. According to analysis from StockScan, the average price forecast for NVO in 2025 is projected to be $152.12, indicating a significant increase of approximately 15.31% from today’s price​​. This bullish trend seems to continue with higher projections into the following years, suggesting robust growth potential for the company.

WallStreetZen offers a slightly more conservative perspective, with a 12-month average price target of $126.25, which represents a slight downside potential from the current level. This target is derived from 4 analysts’ predictions, with the majority recommending a strong buy​​.

Considering these insights, it seems that the general consensus among analysts is positive about Novo Nordisk’s future performance, albeit with some variations in the degree of optimism. My opinion, taking into account the company’s strong position in the pharmaceutical industry and its focus on diabetes and obesity care, is that Novo Nordisk is likely to continue its growth trajectory. This is supported by the increasing global demand for diabetes and obesity treatments, which could drive the company’s revenue and stock price upwards. However, it’s important to monitor market and industry trends, as these forecasts are subject to change based on numerous factors including regulatory developments, market competition, and global economic conditions.

Crowdstrike Holdings Inc – Price Prediction

NASDAQ: CRWD : $608.88

The forecasts for Crowdstrike Holdings Inc (CRWD) present a promising outlook for the stock’s future performance. According to StockScan, the average price prediction for CRWD in 2025 stands at $608.88, with potential highs reaching up to $657.88 and lows around $384.26. This projection suggests a significant increase of approximately 90.34% from the current price​​.

In the more immediate term, WallStreetZen’s analysis, based on 37 analysts, indicates an average 12-month price target of $382.11 for CRWD, representing an 18.35% upside potential from the current trading price. The price forecasts from these analysts range from a minimum of $220.00 to a maximum of $435.00​​.

These optimistic projections underscore a strong belief among analysts in Crowdstrike’s growth potential, particularly in the cybersecurity sector, which continues to gain importance in our increasingly digital world. However, it’s crucial for investors to consider these forecasts alongside their own research and analysis, keeping in mind the dynamic nature of the stock market and the various factors that could influence these predictions.

Join the conversation

Your email address will not be published. Required fields are marked *